- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
ELRIG Launches Inaugural US Drug Discovery Conference
The free-to-attend event will take place at Pfizer's Cambridge, MA facility in June 2026.
Apr. 14, 2026 at 1:06pm
Got story updates? Submit your updates here. ›
The Drug Discovery USA 2026 conference will bring together leading scientists to explore innovative approaches for modulating difficult drug targets and advancing the field of precision medicine.Cambridge TodayELRIG, a not-for-profit organization dedicated to the global drug discovery community, has announced the launch of its inaugural Drug Discovery USA 2026 conference. The two-day event will be held at Pfizer's Cambridge, Massachusetts facility and will feature leading speakers from academia and industry discussing emerging multifunctional small molecules and novel biologic modalities for targeting difficult drug targets.
Why it matters
The conference aims to bridge the drug discovery communities in Europe and the US, providing US-based scientists easier access to high-quality science and networking opportunities. It also serves as a platform for international life science companies to engage with the wider drug discovery community.
The details
The conference program will cover recent advances in chemical biology and protein engineering that are expanding the boundaries of pharmacological target modulation. Topics will include emerging multifunctional small molecule and biologic approaches that are reshaping early-stage drug discovery by providing versatile and accessible platforms to modulate challenging targets beyond simple inhibition. The event will also feature a poster award for early career professionals, an exhibition hall with a Breakthrough Zone for start-up companies, and networking opportunities.
- The inaugural Drug Discovery USA 2026 conference will take place on June 16-17, 2026.
The players
ELRIG
A not-for-profit, volunteer-led organization dedicated to the global drug discovery community.
Pfizer
A global biopharmaceutical company that is hosting the Drug Discovery USA 2026 conference at its Cambridge, Massachusetts facility.
Drug Discovery News (DDN)
A media partner that is collaborating with ELRIG to deliver the Drug Discovery USA 2026 conference.
Prof Aled Edwards
The conference director from the Structural Genomics Consortium.
Dr Marija Tadin-Strapps
The conference director from Pfizer.
Dr Swarna Balasubramanian
The conference director from AstraZeneca.
What they’re saying
“ELRIG Drug Discovery USA expands the reach of our renowned, free-to-attend events, providing US-based scientists with easier access high-quality science and networking opportunities, while also acting as a bridgehead for international life science companies to engage with the wider community.”
— Sanj Kumar, CEO of ELRIG
The takeaway
The inaugural Drug Discovery USA 2026 conference represents an important step in fostering greater collaboration between the European and US drug discovery communities, providing a valuable platform for scientists, startups, and industry leaders to share insights and explore new frontiers in pharmacological target modulation.
